gastrointestinal side effects
transient nausea
vomiting
nausea
gastritis
taste fatigue
gastrointestinal side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
transient nausea
vomiting
diarrhea
abdominal pain
anorexia
constipation
dyspepsia
gastrointestinal disorder
melena
taste perversion
gastrointestinal side effects
levocarnitine
oral solution
slow consumption
greater dilution of the solution
decreasing
dosage
gastrointestinal effects
gastrointestinal side effects
patients
taste fatigue
mixing
oral solution with drinks
liquid foods
nervous system
side effects
seizures in patients
preexisting seizure activity
seizure frequency
severity in patients
preexisting seizure activity
nervous system
side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
anxiety
dizziness
hypertonia
insomnia
paresthesia
vertigo
reports from clinical trials of significant hypertriglyceridemia
high doses of levocarnitine
g/day
uremic dialysis patients
metabolic side effects
hypertriglyceridemia
triglyceride levels
effects on triglyceride levels
metabolic side effects
hemodialysis patients
levocarnitine in relation
placebo therapy
hypercalcemia
hyperkalemia
hypervolemia
other side effects
body odor
other side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
accidental injury
fever
peripheral edema
weight decrease
weight increase
headache
pain
pain
body odor
decreasing
dosage
local side effects
chronic hemodialysis patients
levocarnitine in relation
placebo
injection site reactions
musculoskeletal side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
asthenia
leg cramps
mild myasthenia
uremic patients
receiving d,l-carnitine
levocarnitine
hematologic side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
anemia
other side effects
significant increases in platelet aggregation
lack of effect on platelet activity
been reports from clinical trials of significant increases in platelet aggregation
high doses of levocarnitine
g/day
hemodialysis patients
endocrine side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
parathyroid disorder
respiratory side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
bronchitis
cough increase
dyspnea
pharyngitis
rhinitis
sinusitis
dermatologic side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
pruritus
rash
ocular side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
amblyopia
eye disorder
genitourinary side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
urinary tract infection
kidney failure
cardiovascular
side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
arrhythmia
atrial fibrillation
cardiovascular disorder
chest pain
electrocardiogram abnormalities
hemorrhage
hypertension
hypotension
palpitations
tachycardia
vascular disorder
hypersensitivity side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
allergic reactions
causality
side effects
chronic hemodialysis patients
psychiatric side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
depression
drug dependence
immunologic side effects
chronic hemodialysis patients
levocarnitine in relation
placebo therapy
flu syndrome
infection
high blood pressure
fast heartbeat
fever
seizures
stomach cramps
diarrhea 
headache
nausea or vomiting 
abdominal discomfort
body odor
depression
dizziness
impaired vision
loss of appetite
weight
swelling in hands
lower legs
feet
tingling sensation
weakness